Yatsen Group Expands Scientific Presence at Prestigious IFSCC Cosmetics Congress with Record 20 Research Presentations

Yatsen Group (YSG) presented a record 20 research submissions at the 36th IFSCC Congress in Perth, nearly double its 2025 total.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Yatsen Group (YSG) presented a record 20 research submissions at the 36th IFSCC Congress in Perth, nearly double its 2025 total. This marked its fifth consecutive year at the cosmetics science conference. Its studies were selected from more than 1,200 submissions after three rounds of expert review.

The research covered nine fields, including skin microbiome and formulation research. R&D Director Yi Deng presented a microbiology testing method. Yatsen has invested over RMB 770 million in research and development, with annual spending exceeding 3% of revenue for four consecutive years.

Key Figures

Research presentations: 20 presentations R&D investment: Over RMB 770 million Annual R&D spending: More than 3% of revenue for four consecutive years +2 more

Research presentations: 20 presentations; 36th IFSCC Congress; record total
R&D investment: Over RMB 770 million; Reported company investment
Annual R&D spending: More than 3% of revenue for four consecutive years; Company-reported spending
Patent applications: 282 applications; As of June 30, 2026
Academic papers: 55 papers; As of June 30, 2026

Historical Context

1 past event · Latest: Sep 03

1 event

Sep 03
ESG report

24h Move

-6.1%

Reported 11 research papers at the 35th IFSCC Congress, providing the prior-year presentation baseline.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

skin microbiome, computational toxicology, false negatives

3 terms

skin microbiome medical

"skin microbiome, color cosmetics innovation, skin neuroscience"

The skin microbiome is the community of microscopic organisms—primarily bacteria, fungi, viruses and microscopic mites—that live on the surface and in the upper layers of human skin. Its composition varies by body site, age, environment and personal care practices, and it interacts with the skin’s barrier and immune system to influence moisture, odor and susceptibility to irritation; disruption of the normal balance (dysbiosis) is associated with various skin conditions but does not alone determine disease.

computational toxicology technical

"preservative and microbiological science, computational toxicology"

The use of computer-based models, algorithms and data analysis to predict whether and how chemicals, drugs or mixtures cause harmful effects in living organisms. It combines experimental data (for example high-throughput lab tests or chemical properties) with approaches such as quantitative structure–activity relationships (QSAR), physiologically based pharmacokinetic (PBPK) models, machine learning and read‑across to estimate toxicity, exposure and dose–response; these predictions are used to prioritize testing, interpret results and support regulatory submissions but depend on model validation and have inherent uncertainty compared with direct in vivo studies.

false negatives technical

"reduces false negatives, establishing a quality assurance standard"

A false negative is an outcome of a test, screening, or classification process where something that is actually present is incorrectly labeled as absent. It measures the error of missing true positives — for example, a diagnostic test failing to detect a disease that the patient has, or a fraud-detection system overlooking a genuine fraudulent transaction. False negatives reduce a procedure's sensitivity and often occur in trade-off with false positives: making a test stricter to avoid false alarms can increase the chance of false negatives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/15/2026 - 01:31 AM EDT

GUANGZHOU, China, Oct. 15, 2026 /PRNewswire/ -- Yatsen Holding Limited (NYSE: YSG) (Yatsen Group), a leading China-based beauty group, presented a record 20 research submissions at the 36th IFSCC Congress in Perth — nearly double its 2025 total and marking its fifth consecutive year at the world's leading conference for cosmetics science. Yatsen's 20 studies were selected from more than 1,200 submissions following three rounds of expert review, underscoring its sustained investment in scientific innovation and its leading role in China's cosmetics sector.

Yatsen Group's scientific poster presentations accepted at the 36th IFSCC Congress

Breakthroughs Across Nine Cutting-Edge Fields

"IFSCC is a leading science forum in cosmetic industry" said Jing Cheng, Chief Scientific Officer of Yatsen Group. "Achieving a record 20 accepted contributions across our core brands reflects the collaborative strength of our global R&D ecosystem. We remain committed to translating cutting-edge science into high-efficacy beauty solutions for consumers worldwide."

Yatsen's featured research spanned nine cutting-edge fields, including advanced scientific mechanisms, active ingredient innovation, efficacy evaluation, skin microbiome, color cosmetics innovation, skin neuroscience, preservative and microbiological science, computational toxicology, and formulation & delivery system innovation.

At the congress, Yatsen Group's R&D Director, Yi Deng, delivered a podium presentation on a novel microbiology testing methodology that minimizes preservative interference and reduces false negatives, establishing a quality assurance standard more reflective of real-world production across cosmetic formats.

Deng Yi, R&D Director of Yatsen Group, presenting research findings at the 36th IFSCC Congress

Additionally, Yatsen's major brands — DR.WU, Galénic, Eve Lom and Perfect Diary, — presented technological applications spanning gentle skincare, anti-aging, eye-area care, clinical skin research and color cosmetics innovation.

Sustained R&D Commitment

Yatsen's R&D network spans an advanced manufacturing hub, three global R&D centers, six joint laboratories and more than 20 joint research platforms. The Group has invested over RMB 770 million in R&D, with annual spending exceeding 3% of revenue for four consecutive years. As of June 30, 2026, it filed 282 patent applications and published 55 academic papers.

About Yatsen Group

Yatsen Holding Limited (NYSE: YSG) (Yatsen Group) is a leading China-based beauty group with the vision of becoming a world-class beauty innovation pioneer. Founded in 2016, its brands — including Galénic, DR.WU (mainland China business), Eve Lom, Perfect Diary and Little Ondine — cover consumer segments from the mass market to prestige and clinical-grade skincare.

Media Contact:

Website: www.yatsenglobal.com
LinkedIn: www.linkedin.com/company/yatsen
Contact:public.affairs@yatsenglobal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/yatsen-group-expands-scientific-presence-at-prestigious-ifscc-cosmetics-congress-with-record-20-research-presentations-302909531.html